FP047POTENTIAL IMPACT OF TOLVAPTAN ON BLOOD PRESSURE IN THE TEMPO 3:4 PATIENT POPULATION
- Chapman, Arlene Nephrology, University of Chicago Medicine, Chicago, IL, United States
- Devusyt, Oliveir Institute of Physiology, University of Zurich, Zurich, Switzerland
- Gansevoort, Ron Internal Medicine Nephrology, University of Groningen, Groningen, Netherlands
- Perrone, Ron Nephrology, Tufts Medical Center, Boston, MA, United States
- Torres, Vicente Nephrology, Mayo Clinic, Rochester, MN, United States
- Czerwiec, Frank Global Clinical Development, Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, United States
- Pao, Christina GMA, Otsuka Pharmaceutical Development and Commercialization, Princeton, NJ, United States
- 2018-5-18
Published in:
- Nephrology Dialysis Transplantation. - Oxford University Press (OUP). - 2018, vol. 33, no. suppl_1, p. i63-i63
- Language
-
- English
- Open access status
- bronze
- Identifiers
-
- DOI 10.1093/ndt/gfy104.fp047
- ISSN 0931-0509
- Persistent URL
- https://sonar.ch/global/documents/209081
Statistics
Document views: 12
File downloads:
- fulltext.pdf: 0